Bacterial BarCodes and Agilent in Marketing Agreement

A reseller agreement has been announced by Agilent Technologies, Inc. (Palo Alto, CA, USA) and Bacterial BarCodes (Houston, TX, USA) under which Bacterial BarCodes will market the Agilent 2100 bioanalyzer as a key component of a new system called DiversiLab System.

The DiversiLab System will enable users in clinical epidemiology, food safety, and pharmaceutical research to rapidly track the source and spread of a bacterial infection or contamination. Bacterial BarCodes has developed a repetitive sequence-based polymerase chain reaction (rep-PCR)-based DNA fingerprinting technology that will be combined with the Agilent 2100 bioanalyzer and the LabChip and reagents of Caliper Technologies (Hopkinton, MA, USA) to create the DiversiLab System. The Agilent 2100 is a microfluidics-based system for analyzing RNA, DNA, proteins, and cell fluorescence. It performs automated quality control, sizing, and quantification of nucleic acids or proteins, and simple flow cytometric analyses, all on one platform.

"The Agilent 2100 bioanalyzer provides our DiversiLab System with a standardized, automated platform for sample analysis, enabling our customers to quickly and effectively respond to a microbial outbreak,” noted David McWilliams, CEO of Bacterial BarCodes.





Related Links:
Agilent Technologies
Bacterial BarCodes